{"disease":{"id":"chronic-lung-disease","name":"chronic lung disease"},"drugs":{"marketed":[{"drug_id":"prevnar-family","indication_name":"Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F in adults 18 years of age and older with chronic heart disease, chronic lung disease, diabetes mellitus, or functional or anatomical asplenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prevnar family","generic_name":"prevnar-family","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Streptococcus pneumoniae","drug_class":"Vaccine","quality_score":45,"revenue":"6494","mechanism":"Induces an immune response to Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F"},{"drug_id":"vilanterol","indication_name":"Chronic obstructive lung disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Breo Ellipta","generic_name":"VILANTEROL","company_name":"Glaxo Grp Ltd","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":60,"revenue":"3100","mechanism":"Breo Ellipta works by stimulating the beta-2 adrenergic receptor to relax airway muscles and improve breathing."},{"drug_id":"fluticasone-furoate","indication_name":"Chronic obstructive lung disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arnuity Ellipta","generic_name":"FLUTICASONE FUROATE","company_name":"Haleon Us Holdings","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":62,"revenue":"3100","mechanism":""},{"drug_id":"umeclidinium","indication_name":"Chronic obstructive lung disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Incruse Ellipta","generic_name":"UMECLIDINIUM","company_name":"Glaxo Grp England","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M4","drug_class":"Anticholinergic","quality_score":70,"revenue":"3100","mechanism":"Umeclidinium works by blocking the M4 muscarinic acetylcholine receptor to relax airway smooth muscle and improve breathing."},{"drug_id":"15-valent-pneumococcal-conjugate-vaccine-pcv15","indication_name":"Prevention of invasive pneumococcal disease caused by 15 serotypes of Streptococcus pneumoniae in adults 18 years of age and older with chronic lung disease.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"15-valent pneumococcal conjugate vaccine (PCV15)","generic_name":"15-valent-pneumococcal-conjugate-vaccine-pcv15","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Streptococcus pneumoniae","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"glycopyrrolate","indication_name":"Chronic obstructive lung disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Glycopyrrolate","company_name":"Yonsei University","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"almitrine","indication_name":"Chronic obstructive lung disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Duxil","generic_name":"ALMITRINE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"almitrine","quality_score":22,"revenue":null,"mechanism":""},{"drug_id":"aclidinium-bromide","indication_name":"Chronic obstructive lung disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tudorza Pressair","generic_name":"ACLIDINIUM BROMIDE","company_name":"Covis","drug_phase":"marketed","molecular_target":"M3 receptors, beta 2 -adrenergic receptors","drug_class":"Anticholinergic","quality_score":10,"revenue":null,"mechanism":"DUAKLIR PRESSAIR combines aclidinium, an anticholinergic, and formoterol, a beta 2 -adrenergic agonist, to provide bronchodilation in COPD."},{"drug_id":"ipratropium","indication_name":"Chronic obstructive lung disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Atrovent","generic_name":"IPRATROPIUM","company_name":"","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1","drug_class":"Anticholinergic","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"oxitropium","indication_name":"Chronic obstructive lung disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Oxytropium Bromide","generic_name":"OXITROPIUM","company_name":"","drug_phase":"phase_3","molecular_target":"","drug_class":"oxitropium","quality_score":null,"revenue":null,"mechanism":"Oxytropium works by blocking the action of acetylcholine, a neurotransmitter that causes airway muscles to contract."},{"drug_id":"ppsv23","indication_name":"Prevention of invasive disease caused by Streptococcus pneumoniae in adults 2 years of age or older with chronic lung disease, including chronic obstructive pulmonary disease (COPD) and asthma","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ppsv23","generic_name":"ppsv23","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Streptococcus pneumoniae","drug_class":"Vaccine","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"mpnc-candidate","indication_name":"Prevention of invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae in adults 18 years of age and older with chronic heart disease, chronic lung disease, diabetes mellitus, or alcoholism","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"mPnC candidate","generic_name":"mpnc-candidate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Specific protein or receptor involved in disease pathology","drug_class":"Novel therapeutic agent","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"umec","indication_name":"Chronic obstructive lung disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"UMEC","company_name":"Glaxo Grp England","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3","drug_class":"","quality_score":null,"revenue":null,"mechanism":"UmeC is a small molecule drug that works by interacting with a specific target in the body."},{"drug_id":"incruse","indication_name":"Chronic obstructive lung disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Incruse","company_name":"Fundacio Privada Mon Clinic Barcelona","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"brovana","indication_name":"Chronic obstructive lung disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Brovana","company_name":"Wake Forest University Health Sciences","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor, Beta-2 adrenergic receptor, Beta-3 adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"olodaterol","indication_name":"Chronic obstructive lung disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Striverdi Respimat","generic_name":"OLODATEROL","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":55,"revenue":null,"mechanism":"Striverdi Respimat works by stimulating the beta-2 receptors in the lungs to relax airway muscles and improve breathing."},{"drug_id":"sialanar","indication_name":"Chronic obstructive lung disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Sialanar","company_name":"Proveca Pharma Limited","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"revefenacin","indication_name":"Chronic obstructive lung disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Yupelri","generic_name":"REVEFENACIN","company_name":"Mylan Ireland Ltd","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M3","drug_class":"Anticholinergic [EPC]","quality_score":10,"revenue":null,"mechanism":"Yupelri works by blocking the action of a chemical called acetylcholine, which stimulates the muscles in the airways, leading to bronchodilation."},{"drug_id":"glycopyrronium-bromide","indication_name":"Chronic obstructive lung disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cuvposa","generic_name":"GLYCOPYRRONIUM BROMIDE","company_name":"Shionogi","drug_phase":"marketed","molecular_target":"Muscarinic acetylcholine receptor M1","drug_class":"Anticholinergic","quality_score":62,"revenue":null,"mechanism":"Cuvposa works by blocking the action of a chemical called acetylcholine, which stimulates the muscarinic receptors in the body."},{"drug_id":"arformoterol","indication_name":"Chronic obstructive lung disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Brovana","generic_name":"ARFORMOTEROL","company_name":"Lupin","drug_phase":"marketed","molecular_target":"Beta-2 adrenergic receptor","drug_class":"beta2-Adrenergic Agonist","quality_score":58,"revenue":null,"mechanism":"Brovana works by activating the beta-2 adrenergic receptor to relax airway muscles and improve breathing."}],"pipeline":[],"offLabel":[],"totalMarketed":20,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT06652776","title":"The Italian Registry of Patients With Chronic Obstructive Pulmonary Disease","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":10000,"lead_sponsor_name":"University of Milan","has_results":false},{"nct_id":"NCT07363980","title":"Coronary Computed Tomography Angiography In Rheumatoid Arthritis Study","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":4000,"lead_sponsor_name":"Ellen Margrethe Hauge","has_results":false},{"nct_id":"NCT04281784","title":"Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)","phase":"NA","overall_status":"COMPLETED","enrollment_count":2512,"lead_sponsor_name":"University of Washington","has_results":true},{"nct_id":"NCT01443845","title":"Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":2354,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT00136006","title":"The Vancouver-BOLD Study: The Burden of Chronic Obstructive Lung Disease","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT03721952","title":"Facilitating Communication Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":977,"lead_sponsor_name":"University of Washington","has_results":true},{"nct_id":"NCT03516994","title":"Reducing Disparities in the Quality of Advance Care Planning for Older Adults","phase":"NA","overall_status":"COMPLETED","enrollment_count":790,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT04283994","title":"Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)","phase":"NA","overall_status":"COMPLETED","enrollment_count":756,"lead_sponsor_name":"University of Washington","has_results":true},{"nct_id":"NCT04142710","title":"Pragmatic Randomized Control Trial of Telehealth vs Standard Care in Follow-up of Patients With Chronic Conditions","phase":"NA","overall_status":"COMPLETED","enrollment_count":732,"lead_sponsor_name":"University of Oslo","has_results":false},{"nct_id":"NCT05209607","title":"Social Media-based Bundle Care of AECOPD Patients.","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":648,"lead_sponsor_name":"Beijing Chao Yang Hospital","has_results":false},{"nct_id":"NCT04628039","title":"Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs","phase":"","overall_status":"COMPLETED","enrollment_count":622,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT03018717","title":"Integral Clinical Plan Shared With or Without Telemonitoring of Constants in Patient With Chronic Diseases","phase":"NA","overall_status":"UNKNOWN","enrollment_count":510,"lead_sponsor_name":"Fundación Pública Andaluza Progreso y Salud","has_results":false},{"nct_id":"NCT04843345","title":"Sjogren's Lung Study","phase":"","overall_status":"SUSPENDED","enrollment_count":500,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT03388476","title":"Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":500,"lead_sponsor_name":"University of Giessen","has_results":false},{"nct_id":"NCT06870032","title":"Pulmonary Rehabilitation and Quality of Life in Children With Chronic Lung Diseases: A Multidisciplinary Approach","phase":"NA","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Horus University","has_results":false},{"nct_id":"NCT06374277","title":"Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence","phase":"NA","overall_status":"RECRUITING","enrollment_count":388,"lead_sponsor_name":"University of Tennessee","has_results":false},{"nct_id":"NCT05830318","title":"Usability and Acceptability Study of the P-STEP Mobile Application","phase":"","overall_status":"UNKNOWN","enrollment_count":380,"lead_sponsor_name":"University of Leicester","has_results":false},{"nct_id":"NCT03253263","title":"A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":338,"lead_sponsor_name":"OHB Neonatology Ltd.","has_results":false},{"nct_id":"NCT02713347","title":"Advancing Symptom Alleviation With Palliative Treatment","phase":"NA","overall_status":"COMPLETED","enrollment_count":306,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT06251271","title":"Diagnosing Obstructive Lung Disease With Point of Care Ultrasound","phase":"","overall_status":"COMPLETED","enrollment_count":301,"lead_sponsor_name":"Soroka University Medical Center","has_results":false},{"nct_id":"NCT02950142","title":"Evidence-based Laboratory Test Order Sets in Primary Care","phase":"NA","overall_status":"COMPLETED","enrollment_count":288,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT02988388","title":"Lung Tissue Research Consortium","phase":"","overall_status":"COMPLETED","enrollment_count":247,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT04107701","title":"Indoor Air Quality and Respiratory Morbidity in School-Aged Children With BPD","phase":"","overall_status":"UNKNOWN","enrollment_count":240,"lead_sponsor_name":"Boston Children's Hospital","has_results":false},{"nct_id":"NCT06897410","title":"Reforça't: A Community, Social, and Healthcare Program for Patients With Cardiorespiratory Conditions Upon Hospital Discharge","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Corporació de Salut del Maresme i la Selva","has_results":false},{"nct_id":"NCT07364682","title":"Measuring Heart Health in Both Term, Preterm and Unwell Newborn Babies With an Advanced Ultrasound Method: Speckle Tracking Echocardiography","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":190,"lead_sponsor_name":"Birmingham Women's NHS Foundation Trust","has_results":false},{"nct_id":"NCT05227547","title":"Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":186,"lead_sponsor_name":"Centre Hospitalier Intercommunal Creteil","has_results":false},{"nct_id":"NCT02622412","title":"Evaluation of a Multi-professional Breathlessness Service for Patients With Breathlessness Due to Any Advanced Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":183,"lead_sponsor_name":"Ludwig-Maximilians - University of Munich","has_results":false},{"nct_id":"NCT03746392","title":"Project to Improve Communication About Serious Illness - Pilot Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"University of Washington","has_results":true},{"nct_id":"NCT03461887","title":"Home-based Exercise Training for COPD Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":123,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT07451977","title":"Effects of Oxygen Supplementation During the 6-Minute Walk Test in Chronic Respiratory Failure or Exertional Hypoxemia","phase":"NA","overall_status":"RECRUITING","enrollment_count":114,"lead_sponsor_name":"Istituti Clinici Scientifici Maugeri SpA","has_results":false},{"nct_id":"NCT03718780","title":"Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exercise","phase":"NA","overall_status":"UNKNOWN","enrollment_count":105,"lead_sponsor_name":"Centre Hospitalier Metropole Savoie","has_results":false},{"nct_id":"NCT03506906","title":"The Debated Role of Sleep Studies in Patients Under Established Home Mechanical Ventilation","phase":"NA","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Wissenschaftliches Institut Bethanien e.V","has_results":false},{"nct_id":"NCT05631132","title":"May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Medical University of Silesia","has_results":false},{"nct_id":"NCT07460999","title":"Singing Training vs Usual Care 6-18 Months After Surgical Resection for Non-small Cell Lung Cancer (NSCLC)","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Zealand University Hospital","has_results":false},{"nct_id":"NCT05299385","title":"The Study for Evaluating the Clinical Effectiveness and Safety of Respiratory Rehabilitation Software 'Redpill Breath'(COPD, Asthma, Lung Cancer, Etc.)","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Lifesemantics Corp.","has_results":false},{"nct_id":"NCT07151768","title":"Prospective Validation of the Novel PVD-B65 Risk Score in Patients With Chronic Lung Disease and Pulmonary Hypertension","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Temple University","has_results":false},{"nct_id":"NCT06713512","title":"InvEstigating oeStrogen Signalling and the Effect upoN the exTracelluar Matrix In pAtients With Obstructive Lung Disease","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT02784821","title":"Antibiotic \"Dysbiosis\" in Preterm Infants","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":98,"lead_sponsor_name":"University of Florida","has_results":true},{"nct_id":"NCT05504993","title":"Are Comorbidities Related to Frequent Severe Exacerbations of AECOPD","phase":"","overall_status":"COMPLETED","enrollment_count":92,"lead_sponsor_name":"Ankara University","has_results":false},{"nct_id":"NCT05214508","title":"Serum Interleukin 6 in Chronic Obstructive Pulmonary Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Beni-Suef University","has_results":false},{"nct_id":"NCT05025774","title":"Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise","phase":"","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT06110481","title":"Reversibility of Bronchial Obstruction in Children Born Preterm","phase":"","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Charles University, Czech Republic","has_results":false},{"nct_id":"NCT07075835","title":"Enhanced External Counterpulsation for Patients With Ventilation Disorders","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":80,"lead_sponsor_name":"I.M. Sechenov First Moscow State Medical University","has_results":false},{"nct_id":"NCT06592235","title":"Awareness of Individuals with Chronic Lung Disease About Climate Change, Heat Waves, Air Pollution and Physical Activity","phase":"","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Hacettepe University","has_results":false},{"nct_id":"NCT04711057","title":"CENTR(AR): Lungs Moving","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Aveiro University","has_results":false},{"nct_id":"NCT05565872","title":"Effects of Supervision During a Community-based Exercise Intervention (Urban Training) in Patients With COPD","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Universidad Complutense de Madrid","has_results":false},{"nct_id":"NCT03620071","title":"GoalKeeper: Intelligent Information Sharing for Children With Medical Complexity","phase":"NA","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT05029557","title":"The Effect of Education Based on the Chronic Care Model in COPD Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Hasan Kalyoncu University","has_results":false},{"nct_id":"NCT06022627","title":"EFFECT OF PRANAYAMA YOGA ON COPD","phase":"NA","overall_status":"UNKNOWN","enrollment_count":66,"lead_sponsor_name":"Yeditepe University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}